Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record.

August 31, 2024

Reassessed

Butidrine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Corbadrine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
MMAI (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Menatetrenone (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Methedrone (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
Oxyfedrine (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)

Assessed

GM-2505 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Pharmacology of selegiline (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Racephedrine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

August 30, 2024

Reassessed

Cicloprolol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Pharmacy Council of Nigeria (talk) reassessed. Quality rating changed from NA-Class to Stub-Class. (rev · t)
Prenalterol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

Draft:Theophylline ephedrine (talk) assessed. Importance assessed as NA-Class. (rev · t)

August 29, 2024

Reassessed

Phenaglycodol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

Desglymidodrine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
University of Minnesota College of Pharmacy (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

August 28, 2024

Reassessed

Brotizolam (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Odronextamab (talk) reassessed. Importance rating changed from Unknown-Class to Mid-Class. (rev · t)

Assessed

SER150 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

August 27, 2024

Reassessed

Condoliase (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Vitamin K antagonist (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Xenobiotic-sensing receptor (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

August 25, 2024

Renamed

Draft:List of investigational social anxiety disorder drugs renamed to List of investigational social anxiety disorder drugs.

Assessed

Healing Galing (talk) assessed. Quality assessed as Redirect-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
Zada Mary Cooper (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)